Do patients with functional chest pain have neuroplastic reorganization of the pain matrix? A diffusion tensor imaging study
-
Jens Brøndum Frøkjær
, Andra Sorina Boldea
Abstract
Background and aims
In functional chest pain (FCP) of presumed esophageal origin central nervous system hyperexcitability is generally believed to play an important role in pain pathogenesis. However, this theory has recently been challenged. Using magnetic resonance diffusion tensor imaging, the aim was to characterize any microstructural reorganization of the pain neuromatrix in FCP patients.
Methods
13 FCP patients and 20 matched healthy controls were studied in a 3T MR scanner. Inclusion criteria were relevant chest pain, normal coronary angiogram and normal upper gastrointestinal evaluation. Apparent diffusion coefficient (ADC) (i.e. mean diffusivity of water) and fractional anisotropy (FA) (i.e. directionality of water diffusion as a measure of fiber organization) values were assessed in the secondary sensory cortex, cingulate cortex, insula, prefrontal cortex, and amygdala.
Results
Overall, including all regions, no difference in ADC and FA values was found between the patients and controls (P = 0.79 and P = 0.23, respectively). Post-hoc tests revealed no difference in ADC and FA values of the individual regions. However, a trend of patients having increased ADC in the mid insula grey matter and increased FA in the mid insula white matter was observed (both P = 0.065).
Conclusions
This explorative study suggests that microstructural reorganization of the central pain neuromatrix may not be present in well-characterized FCP patients.
Implications
This finding, together with recent neurophysiologal evidence, challenges the theory of visceral hypersensitivity due to changes in the central nervous system in FCP patients.
1 Introduction
Functional chest pain (FCP) of presumed esophageal origin is considered to be the second most common esophageal cause of chest pain, only exceeded by gastro-esophageal reflux disease (GERD) [1,2]. The pain is typically recurrent, leading to numerous hospital admissions, which are mostly without finding of any specific treatable cause of the pain. FCP is associated with reduced quality of life and major socioeconomic costs [3,4]. The Rome III diagnostic criteria described FCP as “episodes of unexplained chest pain that usually are midline in location and of visceral quality, and therefore potentially of esophageal origin” [2]. Exclusion of GERD and dysmotility based appropriate tests is mandatory together with a negative cardiological examination. Furthermore, the criteria have to be fulfilled for 3 consecutive months with symptom onset at least 6 months before diagnosis.
The pathogenesis of pain in FCP is not clear, but visceral hypersensitivity is proposed to be essential [5,6]. It is evident that more insight into the pain pathogenesis is needed, including distinction between central and peripheral mechanisms, to improve management and develop new treatment options. Several studies of unexplained chest pain have been conducted, but the results are not consistent [5,7,8,9,10,11,12]. Recently, the electrophysiological evoked brain response to painful esophageal stimuli was evaluated using advanced methods including inverse source modeling, and no evidence of altered central pain processed was observed [13]. However, few studies have explored whether structural changes in the brain are present in FCP.
Magnetic resonance imaging (MRI) with diffusion tensor imaging (DTI) has the ability to assess changes in white and grey matter microstructure not seen by more conventional imaging techniques [14]. Previously we studied the microstructural brain changes in painful chronic pancreatitis patients and found abnormal microstructure in areas involved in visceral sensory processing indicating structural reorganization of the sensory neuromatrix [15]. DTI based measurements of areas involved in visceral sensory processing have, to the best of our knowledge, never been conducted in FCP patients.
We hypothesized that patients with FCP have changes in brain microstructure in areas involved in the processing of visceral pain. The aim of the study was to assess the brain microstructure described by DTI in white and grey matter areas important for pain processing in healthy controls and patients with FCP.
2 Materials and methods
2.1 Subjects
Thirteen patients with a diagnosis of FCP were included from the Department of Cardiology at Haukeland University Hospital. The demographic and clinical characteristics are given in Table 1 and electrophysiological data from these patients were previously reported [13]. The patients fulfilled the Rome III criteria. Inclusion criteria were: (1) normal cardiac evaluation including coronary angiograms, (2) normal upper gastrointestinal evaluation including conventional manometry using a solid-state catheter, 24-hours impedance/pH-metry recording and gastro-esophageal endoscopy. Exclusion criteria were: (1) concomitant medication interfering with sensation (including antidepressants), (2) history or clinical signs of any pulmonary, musculoskeletal or psychiatric disorders, (3) concomitant disease affecting sensation or compromising the patient’s safety during participation in the study, and (4) prior surgery to the gastrointestinal tract.
Demographic and clinical characteristics of patients and healthy controls.
Patients (N = 13) | Healthy controls (N = 20) | ||
---|---|---|---|
Age (years) | 50.4 ± 7.5 | 46.5 ± 13.8 | |
Age (years) gender specific | |||
Female | 51.6 ± 7.4 (N = 7) | 45.5 ± 16.4 (N = 11) | |
Male | 49.0 ± 8.1 (N = 6) | 47.7 ± 10.8 (N = 9) | |
Disease duration (years) | 5.0 (range 0.8–18.0) | N/A | |
Chest pain – frequency | |||
Daily | 3 | N/A | |
>3 per week | 8 | N/A | |
<3 per week | 2 | N/A | |
Mean chest pain intensity VAS score | 5.7 ± 1.8 | N/A | |
Body mass index | 25.3 ± 2.2 kg/m2 | 24.1 ± 3.2 kg/m2 | |
Blood pressure at rest | |||
Systolic | 136.9 ± 11.5 mm Hg | 130.2 ± 9.3 mm Hg | |
Diastolic | 83.8 ± 7.2 mm Hg | 81.6 ± 7.4 mm Hg | |
Heart rate at rest | 66 ± 7.9 b/min | 68.0 ± 10 b/min | |
Subjects smoking | 3/13 | 1/15 | |
Subjects on any medication | 9/13 | 3/15 | |
Subjects on drugs affecting neural pathways | 0/13 | 0/20 |
-
Data are given as mean ± SD. N: number. N/A: not applicable. VAS: visual analogue scale (0–10). b/min: beats/minutes.
Twenty healthy controls were recruited by advertisement among employees at Haukeland University Hospital. Inclusion criteria were: healthy and without any symptoms suggestive of cardiac or gastrointestinal diseases, or pain disorders.
All subjects had no contraindications to performance of MRI. The study was conducted according to the Helsinki II declaration and oral and written informed consents were obtained from all subjects. The protocol was approved by the local Ethics Committee (No: REK vest 2010/2561-2).
2.2 Magnetic resonance imaging
All subjects were examined at Haukeland University Hospital in a 3T MR scanner (Signa HDxt, General Electrics, Milwaukee, WI, USA) equipped with an 8-channel standard head coil. Axial T2-weighted FLAIR-sequence images (FOV 25 × 25 cm, matrix 352 × 224, 5 mm slice thickness, whole brain coverage, repetition time 8802 ms, echo time 127 ms, and inversion time 2200 ms) were evaluated for relevant pathology by an experienced radiologist. Axial T1-weighted 3D BRAVO-sequence images (FOV 25 × 25 cm, 320 × 320 matrix, 1.0 mm slice thickness, whole head coverage, flip angle 14◦, repetition time 9.0 ms, and echo time 3.6 ms) were obtained for detailed anatomical information. DTI was performed by covering the entire cerebrum and was acquired axially with a single echo diffusion-weighted sequence with eddy current compensation (repetition time 9000 ms, minimum echo time, matrix 128 × 128, field of view 307 mm, slice thickness 2.4 mm, no slice sparing, 40 contiguous slices, 32 diffusion directions, 4 T2 images, and b-value used were 0 and 1300 s/mm2). Prior to each acquisition, automatic whole-volume first order shimming was performed to minimize field inhomogeneity. The DTI examination time was approximately 5 min.
2.3 Analysis of DTI data
DTI measures the magnitude (described by the apparent diffusion coefficient (ADC)) and directionality (described as fractional anisotropy (FA)) of water diffusion in tissues. ADC represents the mean diffusivity of water in all directions, termed isotropic diffusion. In the presence of barriers, such as cell membranes, fibers, and myelin, the diffusion is greater in one direction (anisotropic diffusion). FA provides a quantitative measure of the degree of anisotropic diffusion (FA values range between 0 (isotropy) and 1 (complete anisotropy)), and is high in regularly organized and structured white matter such as the corpus callosum and lower in less organized tissues such as grey matter. For review see [14].
Analyses of the DTI data were done using NordicICE (Diffusion/DTI Module version 2.3, Nordic Imaging Lab, Bergen, Norway) on a voxel-by-voxel basis. From the diffusion-weighted sequence, ADC and FA values in each voxel were calculated. The ADC and FA values were examined in predefined grey and white matter areas of the brain, and the analyses were performed by the same person (ASB). Files were renamed and personal and clinical data were hidden to make the analysis blind to the investigator. The regions of interest (ROIs) are illustrated in Fig. 1 and were: White matter in relation to (1) anterior, (2) mid and (3) posterior insula, and grey matter of (4) amygdala, (5) anterior, (6) mid and (7) posterior cingulate cortex, (8) anterior, (9) mid and (10) posterior insula, (11) prefrontal cortex, and (12) secondary sensory cortex (SII). DTI parameters were retrieved from bilateral corresponding (i.e. left and right) brain areas, separately.

Illustration of the anatomical positions of the analyzed areas involved in processing of visceral pain. White matter substance was analyzed in the anterior, mid and posterior insula. Grey matter substance was analyzed in amygdala, secondary sensory cortex (SII), cingulate cortex (anterior, mid and posterior), insula (anterior, mid and posterior), and prefrontal cortex.
The anatomical and DTI data were imported into NordicICE, and the DTI module was utilized for computing the FA and ADC maps. The FA and ADC maps where co-registered yielding a map where anatomical structures could be identified. Each ROI was identified using a standardized procedure: First, the area was found and drawn on the co-registered ADC and FA map. Second, the retrieved location was checked by viewing the anatomical scan, thus securing the highest accuracy in placing the ROI in the correct anatomical area. The ROI position was then saved for later retrieval. This procedure was repeated for all areas, which were then used to extract appropriate mean values of the individual ROIs from the FA and ADC maps.
2.4 Statistics
Results are expressed as mean ±SD. The difference in age and gender distribution between patients and controls was analyzed using t-test or Fishers exact test as appropriate. To analyze differences in ADC and FA values, a multivariate analysis of variance (MANOVA) was applied with the subject groups (patient vs. control) as fixed factor, the right vs. left side and gender as co-factors and the ADC/FA values of the ROI locations as dependent variables. The ROI positions were selected a priory and the MANOVA model accounted for multiple tests in the computations. This approach was used to limit the likelihood of type II errors which would result in truly important differences being deemed non-significant [16]. Normality was checked by QQ-plots and the assumption of variance homogeneity by Levene’s test. P-values less than 0.05 were considered significant. SPSS Statistics 17.0 (SPSS Inc., Chicago, IL, USA) was used for the analysis.
3 Results
Age and gender were comparable between groups (age: P = 0.18; gender: P = 1.0) (Table 1). Expert evaluation of the MR images concluded that all subjects had normal age-related findings (no excessive atrophy or white matter lesions). No other pathological findings were seen. None of the few white matter lesions were located in or near the ROIs of the FA and ADC measurements.
3.1 ADC measurements, mean diffusion
The mean ADC values of all ROIs are shown in Fig. 2. Overall, no difference in ADC values was found between the patients and controls (F = 0.65, P = 0.79). No side (left vs. right) or gender differences were observed (P = 0.15 and P = 0.82, respectively). The subsequent univariate tests revealed a trend of patients having increased ADC in the mid insula grey matter (F = 3.5, P = 0.065), while clearly no differences between the two groups were found in the other regions (all P-values > 0.15).

Mean water diffusivity (expressed as apparent diffusion coefficient (ADC)) of patients with functional chest pain and healthy controls is presented. Grey (a) and white (b) matter regions of interest are known to be involved in the processing of visceral pain. SII: secondary sensory cortex, MCC: mid cingulate cortex, ACC: anterior cingulate cortex, PFC: prefrontal cortex, PCC: posterior cingulate cortex, post: posterior, ant: anterior, ins: insula.
3.2 FA measurements, fiber organization
The mean FA values of all ROIs are given in Fig. 3. No overall differences in FA values were found between the patients and controls (F = 1.34, P = 0.23). No side (left vs. right) or gender differences were observed (P = 0.22 and P = 0.81, respectively). The univariate tests showed a trend of patients having increased FA in the mid insula white matter (F = 3.5, P = 0.065), while no differences between the two groups were found in the other regions (all P-values >0.09).

Degree of fiber organization (expressed as fractional anisotropy (FA)) of patients with functional chest pain and healthy controls is presented. Grey (a) and white (b) matter regions of interest are known to be involved in the processing of visceral pain. SII: secondary sensory cortex, MCC: mid cingulate cortex, ACC: anterior cingulate cortex, PFC: prefrontal cortex, PCC: posterior cingulate cortex, post: posterior, ant: anterior, ins: insula.
4 Discussion
In well characterized patients with functional chest pain of presumed esophageal origin, we found no significant microstructural changes in grey and white matter areas known to be involved in the processing of visceral pain. The method has proved to be valid by previously identifying microstructural changes of the sensory neuromatrix in both patients with painful chronic pancreatitis and in diabetic neuropathy [15,17]. The results of this explorative study therefore support recent electrophysiological studies where no evidence of altered central pain processing was observed [13]. Hence, the proposed theory of visceral hypersensitivity by central mechanisms in functional chest pain has been further challenged.
4.1 Methodological considerations
DTI measures the magnitude (described as ADC) and directionality (described as FA) of water diffusion in tissues. The exact nature of the neurostructural changes responsible for increased ADC and reduced FA is not clear, but the most accepted hypothesis is that the integrity of the myelin sheath and axonal membrane is reflected by restriction of diffusion perpendicular to the fibers, whereas the integrity of intra-axonal structures (such as microtubules) is reflected by diffusion parallel to the fibers [14]. Decreased FA is a common feature of several diseases associated with neuronal abnormalities, such as schizophrenia, depression, chronic alcohol use, Alzheimer’s disease, and diabetes [14,18,19].
The selection of ROIs in this study was hypothesis driven and based on knowledge of visceral sensory processing [20,21]. This design has proven to be valid in our previous study of painful chronic pancreatitis and diabetic neuropathy [15,17]. Hence, the selected brain areas are involved in the so-called “sensory brain matrix”. The amygdala receives projections from the spinolimbic tracts and has a role in regulating the affective/motivational component of pain [22,23,24]. The prefrontal cortex and anterior cingulate cortex (ACC) are strongly connected and receive projections from the thalamus and other limbic and subcortical structures, which are also central in the processing of visceral pain [24,25]. The prefrontal cortex is mainly involved in cognitive operations relating to the pain experience. Generally, SII activation has been suggested to be involved in attention and rating of strength and quality of pain, insula is involved in integration of visceral sensory and motor function, and cingulate gyrus (including ACC) is involved in the emotional, affective/cognitive response to pain [26,27,28,29,30,31,32].
Patients with functional chest pain are often poorly defined and likely a very heterogeneous group. The strength of our study is the strict selection of patients according to the current Rome III criteria for FCP [2]. We systematically excluded patients with burning chest pain, patients having symptoms or findings indicative of erosive-/non-erosive gastroesophageal reflux disease, and patients having achalasia or esophageal hypercontractile disorders possibly causing pain. Compared with previous studies we had a very homogenous study population. However, due to these restrictions the numbers of participants with “uncontaminated FCP” were small, which carries a risk for type II errors.
An important thing to consider in a study of brain microstructure is if the disease is of sufficient duration for anatomical changes to develop. In the current study ROME III guidelines have been followed requiring that symptoms have been present at least 6 months. If this is sufficient time for microstructural CNS changes to occur is not presently known.
4.2 Visceral sensory processing in patients with functional chest pain
In previous studies exploring pathophysiology of FCP in details, patients have been proposed to have altered central pain processing [5,7,8,9,10,11,12]. Results from the studies were mainly based on electro-physiology and are conflicting as both faster and slower conduction of pain signals have been measured (corresponding to either hyper-or hyposensitivity). The reason for these discrepancies could be that the studies are subject to bias since they failed to exclude patients affected by other conditions known to change visceral sensation, e.g. (1) concomitant GERD, (2) significant mental illness, e.g. anxiety or depression, or (3) treatment with antidepressants or analgesics [33,34,35,36]. Hobson et al. examined a group of non-cardiac chest pain patients where GERD patients (several with severe pathological DeMeester scores) were included and mental status not assessed [12]. In this study it was proposed that non-cardiac chest pain patients could be divided into groups of phenotypic subclasses: Those with (1) reduced pain thresholds and normal to fast conduction of pain signals, (2) reduced pain thresholds but slow conduction of pain signals, and (3) normal pain thresholds. The results leading to Hobson’s groups 1 and 2 could be a bias of the GERD subpopulation or included anxious patients as both conditions can induce central sensitization [12]. None of the patients in the current study had GERD or depression/anxiety, so it was not surprising that all would be classified into Hobson’s group 3 [13]. In contrast Hollerbach et al. examined a better characterized population of 8 non-cardiac chest pain patients where GERD was excluded by pH-metry and no drugs interfering with sensation was accepted [5]. In this study patients had lower thresholds for sensation in the esophagus and shorter latencies on cortical evoked pain response, which would be expected if patients were hypersensitive/hypervigilant. However, no upper endoscopy was performed and thus it was not controlled for concomitant esophageal diseases, which could have biased results towards hypersensitivity. In contrast the study by Smout et al. demonstrated longer latencies and lower amplitudes of evoked cortical potentials in 10 patients with non-cardiac chest pain patients using rapid balloon distension [37]. However, again patients were not comparable to the current study population as all had esophageal motor disorders and chest pain, and upper endoscopy/pH monitoring were not done. Frobert et al. examined 10 patients with syndrome X in a patient population similar to functional chest pain, who had normal upper endoscopies and measured normal latencies but reduced amplitudes of evoked brain potentials following esophageal electrical stimuli [38]. However, no exclusions were made of pH-study pathology, depression and anxiety, or medication potentially interfering with sensation. In line with these conflicting finding we recently conducted an electrophysiological study where we found no differences between patients with well-characterized FCP and controls in resting state electroencephalogram, evoked brain potential characteristics and brain electrical sources [13].
To sum up, several studies have proposed that patients with FCP have altered cerebral processing of esophageal pain. However, the studies are not in agreement of whether the CNS response is increased, decreased, or unchanged. This can largely be explained by the bias of GERD subpopulations, pain modulating medication, anxiety/depression, and small and heterogeneous patient groups. Although our study assessed structural rather than dynamic/functional changes we question central mechanisms (evident as microstructural reorganization) as cause of chest pain, a view supported by the lack of consensus in the previous electrophysiological studies. Alternative possible etiologies of relevance in the induction of pain in these patients could be peripheral changes such as abnormal contractions in the esophageal muscles which as such these may not evoke permanent changes in the CNS [39]. Another possibility is that the functional chest pain patients have changes in the sensitivity only in the time periods of their pain attacks. Such a short lasting pain may not be sufficient in causing long lasting or permanent changes in the CNS. Furthermore, it cannot be excluded that findings from previous electrophysiological studies may be related to other yet unknown pathophysiology in peripheral tissues and nerve afferents, which will invariably affect characteristics of evoked brain potentials.
5 Conclusions
Our findings in this explorative study suggest that microstructural reorganization of the central pain neuromatrix may not be present in well-characterized functional chest pain patients. The mechanism of pain and whether it originates in the esophagus or in the central nervous system is still unknown, and further studies on well-characterized patient groups are highly warranted.
Highlights
Central hyperexcitability is believed to play a role in functional chest pain.
Microstructural reorganization of the pain neuromatrix was assessed.
Microstructural changes were not present in functional chest pain patients.
This challenges the hypothesis that visceral hypersensitivity is due to central changes.
DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2014.01.006.
-
Conflict of interest
All authors declare no conflicts of interest.
Acknowledgments
We acknowledge the Clinical Trial Unit for adults, Haukeland University Hospital for providing time and support during the investigation phase of the study. Furthermore we acknowledge associate professor Renate Grüner at the Department of Radiology, Haukeland University Hospital, for support with MRI. This work has been supported by a grant from Møre and Romsdal Hospital Trust, Department of Research and Development (FOU), and by Karen Elise Jensens Foundation.
Disclosure: All authors declare no conflicts of interest.
Author contribution: DALH performed the investigation; DALH and JGH recruited the patients; ALK, DALH, GD, AMD, JBF designed the study; ASB, JBF analyzed the data; JBF, ASB, DALH, ALK, AMD wrote the paper.
References
[1] Hershcovici T, Achem SR, Jha LK, Fass R. Systematic review: the treatment of noncardiac chest pain. Aliment Pharm Ther 2012;35:5–14.Search in Google Scholar
[2] Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJ. Functional esophageal disorders ROME III. Gastroenterology 2006;130:1459–65.Search in Google Scholar
[3] Eslick GD, Coulshed DS, Talley NJ. Review article: the burden of illness of non-cardiac chest pain. Aliment Pharm Ther 2002;16:1217–23.Search in Google Scholar
[4] Groarke J, O‘Brien J, Go G, Susanto M, Owens P, Maree AO. Cost burden of nonspecific chest pain admissions. Ir J Med Sci 2013;182:57–61.Search in Google Scholar
[5] Hollerbach S, Bulat R, May A, Kamath MV, Upton AR, Fallen EL, Tougas G. Abnormal cerebral processing of oesophageal stimuli in patients with noncardiac chest pain (NCCP). Neurogastroenterol Motil 2000;12:555–65.Search in Google Scholar
[6] Lembo AJ. Visceral hypersensitivity in noncardiac chest pain. Gastroenterol Clin N Am 2004;33:55–60.Search in Google Scholar
[7] Smout AJ, Devore MS, Dalton CB, Castell DO. Cerebral potentials evoked by oesophageal distension in patients with non-cardiac chest pain. Gut 1992;33:298–302.Search in Google Scholar
[8] Paterson WG, Wang H, Vanner SJ. Increasing pain sensation to repeated esophageal balloon distension in patients with chest pain of undetermined etiology. Dig Dis Sci 1995;40:1325–31.Search in Google Scholar
[9] Rao SS, Hayek B, Summers RW. Functional chest pain of esophageal origin: hyperalgesia or motor dysfunction. Am J Gastroenterol 2001;96:2584–9.Search in Google Scholar
[10] Valeriani M, Sestito A, Le PD, De AL, Infusino F, Maiese T, Sgueglia GA, Tonali PA, Crea F, Restuccia D, Lanza GA. Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J 2005;26:975–82.Search in Google Scholar
[11] Drewes AM, Pedersen J, Reddy H, Rasmussen K, Funch-Jensen P, Arendt-Nielsen L, Gregersen H. Central sensitization in patients with non-cardiac chest pain: a clinical experimental study. Scand J Gastroenterol 2006;41:640–9.Search in Google Scholar
[12] Hobson AR, Furlong PL, Sarkar S, Matthews PJ, Willert RP, Worthen SF, Unsworth BJ, Aziz Q. Neurophysiologic assessment of esophageal sensory processing in noncardiac chest pain. Gastroenterology 2006;130:80–8.Search in Google Scholar
[13] Hoff DA, Krarup AL, Lelic D, Olesen SS, Dimcevski G, Hansen TM, Brock C, Hatlebakk JG, Drewes AM. Central response to painful electrical esophageal stimulation in well-defined patients suffering from functional chest pain. Neurogastroenterol Motil 2013;25:e718–27.Search in Google Scholar
[14] Nucifora PG, Verma R, Lee SK, Melhem ER. Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity. Radiology 2007;245:367–84.Search in Google Scholar
[15] Frokjaer JB, Olesen SS, Gram M, Yavarian Y, Bouwense SA, Wilder-Smith OH, Drewes AM. Altered brain microstructure assessed by diffusion tensor imaging in patients with chronic pancreatitis. Gut 2011;60:1554–62.Search in Google Scholar
[16] Perneger TV. What’s wrong with Bonferroni adjustments. Br Med J 1998;316:1236–8.Search in Google Scholar
[17] Frokjaer JB, Andersen LW, Brock C, Simren M, Ljungberg M, Softeland E, Dimcevski G, Yavarian Y, Gregersen H, Drewes AM. Altered brain microstructure assessed by diffusion tensor imaging in patients with diabetes and gastrointestinal symptoms. Diabetes Care 2013;36:662–8.Search in Google Scholar
[18] Cullen KR, Klimes-Dougan B, Muetzel R, Mueller BA, Camchong J, Houri A, Kurma S, Lim KO. Altered white matter microstructure in adolescents with major depression: a preliminary study. J Am Acad Child Adolesc Psychiatry 2010;49:173–83.Search in Google Scholar
[19] Kodl CT, Franc DT, Rao JP, Anderson FS, Thomas W, Mueller BA, Lim KO, Seaquist ER. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 2008;57:3083–9.Search in Google Scholar
[20] Aziz Q, Schnitzler A, Enck P. Functional neuroimaging of visceral sensation. J Clin Neurophysiol 2000;17:604–12.Search in Google Scholar
[21] Frokjaer JB, Egsgaard LL, Graversen C, Softeland E, Dimcevski G, Blauenfeldt RA, Drewes AM. Gastrointestinal symptoms in type-1 diabetes: is it all about brain plasticity? Eur J Pain 2011;15:249–57.Search in Google Scholar
[22] Manning BH, Mayer DJ. The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. J Neurosci 1995;15:8199–213.Search in Google Scholar
[23] Tershner SA, Helmstetter FJ. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray. Brain Res 2000;865:17–26.Search in Google Scholar
[24] Willis WD, Westlund KN. Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 1997;14:2–31.Search in Google Scholar
[25] Mayer EA, Aziz Q, Coen S, Kern M, Labus JS, Lane R, Kuo B, Naliboff B, Tracey I. Brain imaging approaches to the study of functional GI disorders: a Rome working team report. Neurogastroenterol Motil 2009;21:579–96.Search in Google Scholar
[26] Drewes AM, Dimcevski G, Sami SA, Funch-Jensen P, Huynh KD, Le PD, Arendt-Nielsen L, Valeriani M. The “human visceral homunculus” to pain evoked in the oesophagus, stomach, duodenum and sigmoid colon. Exp Brain Res 2006;174:443–52.Search in Google Scholar
[27] Hobson AR, Furlong PL, Worthen SF, Hillebrand A, Barnes GR, Singh KD, Aziz Q. Real-time imaging of human cortical activity evoked by painful esophageal stimulation. Gastroenterology 2005;128:610–9.Search in Google Scholar
[28] Drewes AM, Sami SA, Dimcevski G, Nielsen KD, Funch-Jensen P, Valeriani M, Arendt-Nielsen L. Cerebral processing of painful oesophageal stimulation: a study based on independent component analysis of the EEG. Gut 2006;55:619–29.Search in Google Scholar
[29] Treede RD, Kenshalo DR, Gracely RH, Jones AK. The cortical representation of pain. Pain 1999;79:105–11.Search in Google Scholar
[30] Derbyshire SW. Visceral afferent pathways and functional brain imaging. ScientificWorldJournal 2003;3:1065–80.Search in Google Scholar
[31] Dunckley P, Wise RG, Aziz Q, Painter D, Brooks J, Tracey I, Chang L. Cortical processing of visceral and somatic stimulation: differentiating pain intensity from unpleasantness. Neuroscience 2005;133:533–42.Search in Google Scholar
[32] Schreckenberger M, Siessmeier T, Viertmann A, Landvogt C, Buchholz HG, Rolke R, Treede RD, Bartenstein P, Birklein F. The unpleasantness of tonic pain is encoded by the insular cortex. Neurology 2005;64:1175–83.Search in Google Scholar
[33] Drewes AM, Reddy H, Pedersen J, Funch-Jensen P, Gregersen H, Arendt-Nielsen L. Multimodal pain stimulations in patients with grade B oesophagitis. Gut 2006;55:926–32.Search in Google Scholar
[34] Sami SA, Rossel P, Dimcevski G, Nielsen KD, Funch-Jensen P, Valeriani M, Arendt-Nielsen L, Drewes AM. Cortical changes to experimental sensitization of the human esophagus. Neuroscience 2006;140:269–79.Search in Google Scholar
[35] Farmer AD, Coen SJ, Kano M, Naqvi H, Paine PA, Scott SM, Furlong PL, Lightman SL, Knowles CH, Aziz Q. Psychophysiological responses to visceral and somatic pain in functional chest pain identify clinically relevant pain clusters. Neurogastroenterol Motil 2013, http://dx.doi.org/10.1111/nmo.12245 [Epub ahead of print].Search in Google Scholar
[36] Olden KW. The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs. CNS Spectr 2005;10:891–6.Search in Google Scholar
[37] Smout AJ, DeVore MS, Dalton CB, Castell DO. Cerebral potentials evoked by oesophageal distension in patients with non-cardiac chest pain. Gut 1992;33:298–302.Search in Google Scholar
[38] Frobert O, Arendt-Nielsen L, Bak P, Funch-Jensen P, Peder BJ. Pain perception and brain evoked potentials in patients with angina despite normal coronary angiograms. Heart 1996;75:436–41.Search in Google Scholar
[39] Balaban DH, Yamamoto Y, Liu J, Pehlivanov N, Wisniewski R, DeSilvey D, Mittal RK. Sustained esophageal contraction: a marker of esophageal chest pain identified by intraluminal ultrasonography. Gastroenterology 1999;116:29–37.Search in Google Scholar
© 2013 Scandinavian Association for the Study of Pain
Articles in the same Issue
- Editorial comment
- Central sensitization and visceral hypersensitivity: Facts and fictions
- Topical review
- Mechanisms of visceral pain in health and functional gastrointestinal disorders
- Editorial comment
- From patient observation to potential new therapies—Is old spironolactone a new analgesic?
- Observational study
- Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series
- Editorial comment
- Combining an oral opioid-receptor agonist and the antagonist naloxone: A smart drug design that removes some but not all adverse effects of the opioid analgesic
- Observational study
- Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study
- Editorial comment
- The swinging pendulum of oesophageal pain—Away from the centre back towards the periphery again
- Clinical pain research
- Do patients with functional chest pain have neuroplastic reorganization of the pain matrix? A diffusion tensor imaging study
- Editorial comment
- Female chronic pelvic pain is common and complex
- Observational study
- Female chronic pelvic pain is highly prevalent in Denmark. A cross-sectional population-based study with randomly selected participants
- Editorial comment
- Multiple chemical sensitivity and persistent pain states are related, may be treated with similar procedures?
- Educational case report
- Two of three patients with multiple chemical sensitivity had less symptoms and secondary hyperalgesia after transcranially applied pulsed electromagnetic fields
- Editorial comment
- Evoked potentials through small-fiber pathways – For both clinical and research purposes?
- Topical review
- Assessment of small fibers using evoked potentials
- Editorial comment
- GTP-cyclohydrolase 1 genetics and tetrahydrobiopterin—Modulators of pain hypersensitivity?
- Topical review
- GCH1 variants, tetrahydrobiopterin and their effects on pain sensitivity
- Editorial comment
- Aspects of life and pain
- Systematic review
- Psychosocial aspects of everyday life with chronic musculoskeletal pain: A systematic review
Articles in the same Issue
- Editorial comment
- Central sensitization and visceral hypersensitivity: Facts and fictions
- Topical review
- Mechanisms of visceral pain in health and functional gastrointestinal disorders
- Editorial comment
- From patient observation to potential new therapies—Is old spironolactone a new analgesic?
- Observational study
- Long-term efficacy of spironolactone on pain, mood, and quality of life in women with fibromyalgia: An observational case series
- Editorial comment
- Combining an oral opioid-receptor agonist and the antagonist naloxone: A smart drug design that removes some but not all adverse effects of the opioid analgesic
- Observational study
- Effects of prolonged-release oxycodone/naloxone on pain control, bowel function and quality of life: A prospective observational study
- Editorial comment
- The swinging pendulum of oesophageal pain—Away from the centre back towards the periphery again
- Clinical pain research
- Do patients with functional chest pain have neuroplastic reorganization of the pain matrix? A diffusion tensor imaging study
- Editorial comment
- Female chronic pelvic pain is common and complex
- Observational study
- Female chronic pelvic pain is highly prevalent in Denmark. A cross-sectional population-based study with randomly selected participants
- Editorial comment
- Multiple chemical sensitivity and persistent pain states are related, may be treated with similar procedures?
- Educational case report
- Two of three patients with multiple chemical sensitivity had less symptoms and secondary hyperalgesia after transcranially applied pulsed electromagnetic fields
- Editorial comment
- Evoked potentials through small-fiber pathways – For both clinical and research purposes?
- Topical review
- Assessment of small fibers using evoked potentials
- Editorial comment
- GTP-cyclohydrolase 1 genetics and tetrahydrobiopterin—Modulators of pain hypersensitivity?
- Topical review
- GCH1 variants, tetrahydrobiopterin and their effects on pain sensitivity
- Editorial comment
- Aspects of life and pain
- Systematic review
- Psychosocial aspects of everyday life with chronic musculoskeletal pain: A systematic review